Charles River Laboratories International (CRL) Free Cash Flow (2018 - 2026)
Charles River Laboratories International (CRL) free cash flow from Sep 29, 2018 to Mar 28, 2026. The TTM Charles River Laboratories International (CRL) free cash flow is $607M. You can adjust inflation or export chart.
All data is split-adjusted. You can find the most accurate data from the reports on the SEC official website. We recommend verify information using official company filings before making investment decisions.
Annual Free Cash Flow
Quarterly Free Cash Flow
Charles River Laboratories International (CRL) Free Cash Flow CAGR table
| Period | CAGR |
|---|---|
| 1 Year TTM | +6.01% |
| 3 Years TTM | +14.63% |
| 5 Years TTM | +50.27% |
| All Time TTM | +29.62% |
Annual Free Cash Flow change of Charles River Laboratories International (CRL)
| Year | Free Cash Flow | Change |
|---|---|---|
| 2026 | $41M | -94.43% |
| 2025 | $738M | +0.42% |
| 2024 | $735M | +7.41% |
| 2023 | $684M | +10.37% |
| 2022 | $620M | -18.55% |
| 2021 | $761M | N/A |
| 2020 | $0 | N/A |
| 2019 | $0 | -100.00% |
| 2018 | $441M | N/A |
Comparison Charles River Laboratories International (CRL) five years free cash flow CAGR with competitors
Charles River Laboratories International (CRL) five years free cash flow CAGR is 42.96%.
| Ticker | Name | five years Free Cash Flow CAGR | Upside |
|---|---|---|---|
| CDNA | Caredx Inc | 83.64% | +94.67% |
| EXAS | Exact Sciences Corp | 37.68% | -12.31% |
| CSTL | Castle Biosciences Inc | 24.94% | -41.95% |
| MEDP | Medpace Holdings Inc | 24.83% | -42.21% |
| PSNL | Personalis Inc | 11.39% | -73.49% |
| ICLR | Icon Plc | 10.77% | -74.94% |
| GH | Guardant Health Inc | 10.63% | -75.26% |
| IDXX | Idexx Laboratories Inc | 10.21% | -76.25% |
| RDNT | Radnet Inc | 8.77% | -79.59% |
| QGEN | Qiagen NV | 6.88% | -83.99% |
| MTD | Mettler-Toledo International Inc | 1.98% | -95.40% |
| ILMN | Illumina Inc | 1.82% | -95.76% |
| IQV | IQVIA Holdings Inc | 0.31% | -99.29% |